- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Adagio Medical Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.12. | Adagio Medical picks medtech veteran Todd Usen as new CEO | 2 | MassDevice | ||
| 16.12. | Adagio Medical ernennt neuen CEO und Vorstandsvorsitzenden | 2 | Investing.com Deutsch | ||
| 16.12. | Adagio Medical Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| ADAGIO MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.11. | Adagio Medical reports Q3 results | 2 | Seeking Alpha | ||
| 14.11. | Adagio Medical Reports Third Quarter 2024 Results | 51 | Business Wire | LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the "Company" or "Adagio"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias... ► Artikel lesen | |
| 14.11. | Adagio Medical Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 01.11. | Adagio Medical Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.10. | Adagio Medical's VT Cryoablation System begins pivotal FDA study | 1 | Investing.com | ||
| 08.10. | Adagio Medical Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 13.09. | Adagio Medical Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 26.08. | Adagio Medical Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 19.08. | Adagio Medical Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Adagio Medical Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.08. | Adagio Medical goes public in SPAC merger | 1 | MassDevice | ||
| 31.07. | Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias | 158 | Business Wire | LAGUNA HILLS, Calif. & NEW YORK--(BUSINESS WIRE)--Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, announced... ► Artikel lesen | |
| 16.05. | Adagio Medical, Inc.: Adagio Medical Announces First European Commercial Procedures and Commencement of U.S. FDA Pivotal IDE for Ventricular Tachycardia Cryoablation System | 313 | Business Wire | Adagio Medical, Inc. ("Adagio Medical", "Adagio" or the "Company"), a leading innovator in catheter ablation technologies for ventricular tachycardia ("VT") and atrial fibrillation ("AF"), today announced... ► Artikel lesen | |
| 25.03. | Adagio Medical, Inc.: Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers | 436 | PR Newswire | LAGUNA HILLS, Calif., March 25, 2024 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia ("VT") and atrial fibrillation... ► Artikel lesen | |
| 14.02. | Adagio Medical, Inc.: Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies | 402 | PR Newswire | Combined Company expects to receive approximately $42 million from equity and convertible note investors at closing.
LAGUNA HILLS, Calif., Feb. 14, 2024 /PRNewswire/ -- Adagio Medical... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AVINGER | 1,380 | +114,82 % | Avinger Inc - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 83,46 | +2,85 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 76,75 | +0,46 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | -0,78 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| RXSIGHT | 34,305 | -0,82 % | RxSight cut to hold at Stifel on competition concerns | ||
| EUROPEAN WAX CENTER | 5,405 | +4,95 % | European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results | Reiterates fiscal 2024 financial outlook Updates fiscal 2024 outlook for net new centers Third Quarter Fiscal 2024 versus 2023 Net new centers increased 3.7% to 1,064 total centers in 45 statesSystem-wide... ► Artikel lesen | |
| 908 DEVICES | 1,880 | -1,05 % | 908 Devices stock hits 52-week low at $1.82 amidst market challenges | ||
| CASTLE BIOSCIENCES | 27,490 | +0,04 % | Castle Biosciences plant Markteinführung von Neurodermitis-Test bis Ende 2025 | ||
| CVRX | 12,835 | +2,68 % | CVRx, Inc.: CVRx Reports Third Quarter 2024 Financial and Operating Results | MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| TALKSPACE | 3,040 | +1,33 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,620 | +6,77 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP | 4,670 | -5,08 % | WORK Medical Technology Group LTD - F-1, Registration statement for certain foreign private issuers | ||
| ALIGNMENT HEALTHCARE | 10,610 | -0,93 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
| PROGYNY | 14,480 | -0,07 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ADAPTHEALTH | 10,070 | -0,98 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
Das Unternehmen ADAGIO MEDICAL HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,979 Euro und damit -10,16 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADAGIO MEDICAL HOLDINGS INC finden Sie auf Wallstreet Online.
